￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Has the innovative lung cancer drug dacomitinib been approved for marketing in China?

2025-10-19 11:44:20

Check Details
Xacori, the first drug approved for the treatment of ROS-1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Nivolumab has significant effect in treating non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Xalkori is used to treat ALK-positive locally advanced or metastatic non-small cell lung cancer

2025-10-19 11:44:20

Check Details
New drug for lung cancer; Dacomitinib can significantly improve progression-free survival of patients

2025-10-19 11:44:20

Check Details
ALK lung cancer drug Alectinib’s medical insurance reimbursement ratio in 2021

2025-10-19 11:44:20

Check Details
Contraindications and precautions for patients with lung cancer taking Xalkori

2025-10-19 11:44:20

Check Details
Iressa is the first-line treatment option for non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What are the indications for which the immune drug nivolumab is approved by the FDA?

2025-10-19 11:44:20

Check Details
Anshengsa has good results in treating ALK-positive lung cancer

2025-10-19 11:44:20

Check Details
How much does the targeted lung cancer treatment drug Iressa cost per month?

2025-10-19 11:44:20

Check Details
How long can patients with lung cancer take Iressa?

2025-10-19 11:44:20

Check Details
Category
相关知识